Symeres

Kerkenbos 1013
6546 BB Nijmegen
NL
Symeres
Foundation date
25/06/1997
Sector
#Biotechnology / R&D ServicesSubsector
- #R&D Services - CMO (Contract Manufacturing Organization)
- #R&D Services - CRO (Contract Research Organization)
Therapeutic areas
- #Cardiovascular
- #Digestive system
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the ear
- #Diseases of the eye
- #Diseases of the nervous system
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Injury - poisoning and certain other consequences of external causes
- #Mental and behavioural disorders
- #Neoplasms / cancer / oncology
- #Respiratory system
- #Skin and subcutaneous tissue
We are a CRO for services in synthetic chemistry. We offer the following services:
Discovery Chemistry;
Medicinal Chemistry;
Parallel Chemistry;
Scale-up Synthesis;
Process Chemistry, including GMP synthesis up to a few kg.
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2405 '22
PrecisionMed Expo & Summit
Event by: Smart Planet Media International -
2405 '22
EMERGE GHI
Event by: Smart Planet Media International
Latest news
More news-
Latest field trials validate strength of Biotalys’ first biocontrol Evoca
Thursday May 19th 2022
Read more
-
Belgian biotech in European Top-3 despite turbulent times
Wednesday May 18th 2022
Read more
-
KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus
Wednesday May 18th 2022
Read more